ClinConnect ClinConnect Logo
Search / Trial NCT06056232

Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation

Launched by PEKING UNIVERSITY · Sep 20, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how different levels of a program called "distress tolerance intervention" can help people who are feeling emotionally distressed. The researchers want to see if giving more of this intervention makes mindfulness techniques—ways to focus the mind and calm feelings—more effective in reducing emotional distress. They will also explore if the ability to tolerate distress plays a role in how well mindfulness works for these individuals.

To participate in this study, you need to be between 18 and 65 years old and have a certain level of emotional distress, as measured by a specific scale. You should have been on any medication for at least four weeks without changes and must agree to take part voluntarily by signing a consent form. However, people who meditate frequently, have certain mental health conditions, or are at risk of suicide won't be eligible. If you join the study, you'll be helping researchers learn more about how mindfulness can be tailored to better support those dealing with emotional difficulties.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-65;
  • Subjects with scores greater than 21 on the Kessler Psychological Distress Scale.
  • If taking medication, haven't changed for at least 4 weeks before intervention onset and no change in medicine is expected;
  • Voluntary participation in this study and sign an informed consent form.
  • Exclusion Criteria:
  • Subjects who have participated in mindfulness-based projects (especially MIED), and/or the current frequency of meditation practice is more than once a week;
  • Patients with schizophrenia or psychotic affective disorder, current organic mental disorder, substance abuse disorder, and generalized developmental disorder;
  • Subjects at risk of suicide.

About Peking University

Peking University is a prestigious institution located in Beijing, China, recognized for its commitment to advancing medical research and education. As a clinical trial sponsor, Peking University leverages its extensive academic resources and collaborative networks to drive innovative healthcare solutions. The university's focus on rigorous scientific methodologies and adherence to ethical standards ensures the integrity and reliability of its clinical research initiatives. By fostering interdisciplinary partnerships, Peking University aims to translate groundbreaking discoveries into tangible health benefits, contributing to the global advancement of medical science.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Xinghua Liu

Principal Investigator

School of Psychological and Cognitive Sciences, Peking University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported